NCT02182284View on ClinicalTrials.gov

Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 29, 2008

Conditions
Healthy
Interventions
DRUG

low dose BI 201335 NA soft gelatine capsule (SGC)

DRUG

high dose BI 201335 NA soft gelatine capsule (SGC)

DRUG

low dose BI 201335 NA powder in bottle (PIB)

DRUG

high dose BI 201335 NA powder in bottle (PIB)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY